Recent

% | $
Quotes you view appear here for quick access.

NPS Pharmaceuticals, Inc. Message Board

  • showman01 showman01 May 2, 2013 10:04 AM Flag

    Earnings Call Forecast

    Having held this stock for 5 years+ I think I can guess on the general tenor of the earnings call.

    Likely Comments:
    Continuing to execute on plans to roll out GATTEX and NETPARA.
    Moving ahead with GATTEX filings to add pediatric indications.
    GATTEX patient enrollment ahead of goals.
    NATPARA on track for Q3 or 4 submission for BLA
    Sensipar continues to outperform. Non-Recource debt paid off Q1-2 , 2014
    A few new compounds coming onto the radar.

    Maybe Comments:
    NATPARA ahead of filing achedule!
    GATTEX enrollment numbers now look to exceed 1000 by Q1 14!
    Sensipar royalties growing ao fast we are paying of non-recourse debt early!
    Insurance comapnies world-wide add GATTEX to formulary!

    Unlikely Comments:
    Major Pharma in talks with NPSP on potential relationship to enhance shareholder value!!

    As you can see lots of potential here.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
NPSP
45.970.00(0.00%)Feb 20 3:59 PMEST